3 insiders bought €7.1M of shares over the last 90 days, the latest filed 17 Aug 2026.
This page follows insider dealings at Apollomics Inc. as filed with SEC (Form 4). From 18 October 2025 to 18 October 2026, the disclosure feed for Apollomics Inc. logged 25 filings by 9 insiders.
The flow runs one way only: 3 insiders bought (5 purchases totalling €7.1M) and nobody sold on the market. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Chen Hung-Wen filed the largest purchase, €3.5M, on 17 August 2026, which represents 12.2% of the company's market value. The buyers include 1 finance chief, 1 senior executive and 1 chief executive.
For context, the typical company on the same exchange (median of 5,458 companies) published 22 filings over the same period, against 25 filings here. Since 2026, the database holds 5 purchases and no sales by insiders of the company.
The data flag 5 purchases as part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. The last insider purchase was made public on 17 August 2026, 62 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4.
Other companies in the same market with recent insider buying flagged by our signals: GameStop Corp. and Heico Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2025 · cache
25 of 25 declarations
Apollomics Inc. is a biopharmaceutical company focused on developing innovative treatments for cancer. It is listed on the NASDAQ under the ticker APLM.
Purchases our model currently ranks for the recommendations list.
All recommendations